Skip to content

Faculty profile

Changiz Taghibiglou

Back to faculty
Associate ProfessorDepartment of Anatomy, Physiology and PharmacologyUniversity of Saskatchewan

Latest papers

  • Non-Competitive AMPA Receptor Antagonist Perampanel Inhibits Ischemia-Induced Neurodegeneration and Behavioral Deficits in Focal Cortical Pial Vessel Disruption Stroke Model.

    Cells · 2025

  • The Anti-Parkinsonian A2A Receptor Antagonist Istradefylline (KW-6002) Attenuates Behavioral Abnormalities, Neuroinflammation, and Neurodegeneration in Cerebral Ischemia: An Adenosinergic Signaling Link Between Stroke and Parkinson's Disease.

    International journal of molecular sciences · 2025

  • The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioral Deficits after Chronic Stimulation of Adenosine A1 Receptors.

    International journal of molecular sciences · 2024

All 22 publications

Latest funding

  • Role of cellular prion protein in trafficking of GluA2-containing AMPA receptors to the neuronal lipid rafts

    NSERC · 2013 · Principal investigator

    $192,000
All 1 grants and awards

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction